rs114623441
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS1
The NM_001005361.3(DNM2):c.386-6T>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000213 in 1,614,076 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001005361.3 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNM2 | NM_001005361.3 | c.386-6T>A | splice_region_variant, intron_variant | ENST00000389253.9 | NP_001005361.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNM2 | ENST00000389253.9 | c.386-6T>A | splice_region_variant, intron_variant | 5 | NM_001005361.3 | ENSP00000373905.4 |
Frequencies
GnomAD3 genomes AF: 0.00107 AC: 162AN: 152090Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000278 AC: 70AN: 251404Hom.: 0 AF XY: 0.000243 AC XY: 33AN XY: 135882
GnomAD4 exome AF: 0.000124 AC: 182AN: 1461868Hom.: 1 Cov.: 32 AF XY: 0.000114 AC XY: 83AN XY: 727238
GnomAD4 genome AF: 0.00106 AC: 161AN: 152208Hom.: 1 Cov.: 32 AF XY: 0.00106 AC XY: 79AN XY: 74426
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 07, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Mar 19, 2018 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 01, 2020 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Charcot-Marie-Tooth disease dominant intermediate B Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 20, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at